乙酸与安慰剂作为慢性偏头痛辅助治疗:一个随机对照试验
Ghader Mohammadnezhad1,2, Farhad Assarzadegan1,3, Mohsen Koosha1,4
1Clinical Research Development Center, Imam Hossein Educational Hospital, shahid Beheshti University of Medical Sciences, Tehran, Iran.
Headache
|September 2, 2024
概括
每天2000毫克的eicosapentaenoic acid (EPA) 补充剂显著减少了慢性偏头痛患者的偏头痛日和发作. 这表明EPA的EPA建议.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 慢性偏头痛,定义为每月≥15个头痛日,需要有效的预防策略.
- 乙酸 (EPA) 是一种omega-3脂肪酸,具有抗炎性质,具有潜在的治疗益处.
- 调查EPA在慢性偏头痛管理中的作用对于开发新型治疗方法至关重要.
研究的目的:
- 评估每天2000毫克的eicosapentaenoic acid (EPA) 补充剂用于预防慢性偏头痛的疗效.
- 评估EPA对偏头痛患者头痛频率,严重程度和整体生活质量的影响.
主要方法:
- 一个随机,双盲,安慰剂对照试验进行了8周.
- 参与者每天接受2000毫克EPA或安慰剂.
- 主要结局:头痛影响测试-6 (HIT-6);次要结局:偏头痛几天,严重程度,止痛药使用.
主要成果:
- 服用EPA补充剂显著减少每月偏头痛的几天 (p < 0.001) 和偏头痛发作的数量 (p < 0.001).
- 虽然HIT-6得分显示了EPA组的改善趋势 (-6.96对-4.43),但这并没有达到统计学意义 (p=0.084).
- 两组之间没有观察到头痛严重程度或止痛药消费的显著差异. 不良事件是轻微的和可比的.
结论:
- 每天2000毫克EPA显示出作为慢性偏头痛的预防疗法的潜力.
- EPA有效地减少了偏头痛的频率和头痛的日子,改善了患者的生活质量.
- 需要进一步的研究来优化EPA剂量,并确认其在慢性偏头痛管理中的长期疗效.
相关概念视频
01:17Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
01:21Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
01:30Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
01:20Antiepileptic Drugs: Potassium Channel Activators
150
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
150